Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: A vaccination study in twins

Lancet

Volumn 360, Issue 9338, 2002, Pages 991-995

  Höhler, Thomas ^a   Reuss, Esther ^a   Evers, Nina ^a   Dietrich, Evi ^a   Rittner, Christian ^a   Freitag, Christine M ^b   Vollmar, Jens ^c   Schneider, Peter M ^a   Fimmers, Rolf ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c GLAXOSMITHKLINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HLA DR ANTIGEN; VIRUS PROTEIN;

ADULT; ALLELE; ANALYTIC METHOD; ANTIBODY RESPONSE; ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEREDITY; HERITABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TWINS; VACCINATION;

EID: 0037190611     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11083-X     Document Type: Article

References (28)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med. 337:1997;1733-1745.
2. Hill A.V. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet. 2:2001;373-400.
3. Karayiannis P., Alexopoulou A., Hadziyannis S., et al. Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology. 22:1995;1628-1634.
4. Thursz M.R., Kwiatkowski D., Allsopp C.E., Greenwood B.M., Thomas H.C., Hill A.V. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 332:1995;1065-1069.
5. Hohler T., Gerken G., Notghi A., et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol. 26:1997;503-507.
6. Ahn S.H., Han K.H., Park J.Y., et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology. 31:2000;1371-1373.
7. Almarri A., Batchelor J.R. HLA and hepatitis B infection. Lancet. 344:1994;1194-1195.
8. Thio C.L., Thomas D.L., Carrington M. Chronic viral hepatitis and the human genome. Hepatology. 31:2000;819-827.
9. Hohler T., Kruger A., Gerken G., Schneider P.M. Meyer zum Buschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol. 111:1998;579-582.
10. Martin M.P., Harding A., Chadwwick R., et al. Characterization of 12 microsatellite loci of the human MHC in a panel of reference cell lines. Immunogenetics. 47:1998;503.
11. Thoelen S., Van Damme P., Leentvaar-Kuypers A., et al. The first combined vaccine against hepatitis A and B: an overview. Vaccine. 17:1999;1657-1662.
12. Bein G., Glaser R., Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens. 39:1992;68-73.
13. SAS. SAS/ETS Software: Changes and Enhancements through Release 6.12. Cary: SAS Institute Inc, 1997.
14. Vogel F., Motulsky A. Human genetics: problems and approaches. 3rd edn: 1997;Springer, Berlin.
15. Neale M., Cardon L. Methodology for genetic studies of twins and families. 1992;Kluwer Academic Press, Dordrecht.
16. Neale M., Boker S., Xie G., Maes H. MX: statistical modeling. 5th edn: 1999;Department of Psychiatry, Richmond.
17. Jepson A., Banya W., Sisay-Joof F., et al. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens. Infection Immunity. 65:1997;872-876.
18. Lemon S.M., Thomas D.L. Vaccines to prevent viral hepatitis. N Engl J Med. 336:1997;196-204.
19. Desombere I., Willems A., Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens. 51:1998;593-604.
20. Craven D.E., Awdeh Z.L., Kunches L.M., et al. Nonresponsiveness to hepatitis B vaccine in health care workers: results of revaccination and genetic typings. Ann Intern Med. 105:1986;356-360.
21. Hohler T., Meyer C.U., Notghi A., et al. The influence of major histocompatibility complex class II genes and T-cell Vβ repertoire on response to immunization with HbsAg. Hum Immunol. 59:1998;212-218.
22. Thomas H.C., Foster G.R., Sumiya M., et al. Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet. 348:1996;1417-1419.
23. Hohler T., Wunschel M., Gerken G., Schneider P.M., Meyer zum Buschenfelde K.H., Rittner C. No association between mannose-binding lectin alleles and susceptibility to chronic hepatitis B virus infection in German patients. Exp Clin Immunogenet. 15:1998;130-133.
24. Bellamy R., Ruwende C., McAdam K.P., et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. QJM. 91:1998;13-18.
25. Bellamy R., Ruwende C., Corrah T., et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis. 179:1999;721-724.
26. Zhang L., Thursz M.R., Frodsham A., et al. Identification of a gene for chronic hepatitis B virus infection by a genome-wide linkage analysis and family based association studies. Hepatology. 32:2000;392A.
27. Alper C.A., Kruskall M.S., Marcus-Bagley D., et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 321:1989;708-712.
28. Lin T.M., Chen C.J., Wu M.M., et al. Hepatitis B virus markers in Chinese twins. Anticancer Res. 9:1989;737-741.